Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= anticoagulants
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(44)
+
-
Availability
Open access
(29)
+
-
Metadata Only
(15)
+
-
Creation Date
2021
(9)
+
-
2020
(8)
+
-
2018
(6)
+
-
2019
(5)
+
-
2022
(5)
+
-
2014
(3)
+
-
2024
(3)
+
-
2016
(2)
+
-
2023
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(40)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(40)
+
-
Scholarly Publications
(4)
+
-
Topic
anticoagulants
(44)
+
-
hemorrhage
(10)
+
-
atrial fibrillation
(8)
+
-
venous thromboembolism
(7)
+
-
COVID-19
(4)
+
-
international normalized ratio
(4)
+
-
pharmacoepidemiology
(4)
+
-
bleeding
(3)
+
-
factor Xa inhibitors
(3)
+
-
prothrombin time
(3)
+
-
venous thrombosis
(3)
+
-
vitamin K
(3)
+
-
vitamin K antagonist
(3)
+
-
acenocoumarol
(2)
+
-
antithrombins
(2)
+
-
blood coagulation tests
(2)
+
-
calibration
(2)
+
-
cancer
(2)
+
-
coumarins
(2)
+
-
factor X
(2)
+
-
neoplasms
(2)
+
-
phenprocoumon
(2)
+
-
point-of-care testing
(2)
+
-
risk
(2)
+
-
stroke
(2)
+
-
thrombosis
(2)
+
-
treatment outcome
(2)
+
-
Show more
Author
Huisman, M.V.
(18)
+
-
Cannegieter, S.C.
(13)
+
-
Lijfering, W.M.
(12)
+
-
Klok, F.A.
(11)
+
-
Meer, F.J.M. van der
(11)
+
-
Rein, N. van
(11)
+
-
Nierman, M.C.
(6)
+
-
Biedermann, J.S.
(4)
+
-
Kaptein, F.H.J.
(4)
+
-
Kruip, M.J.H.A.
(4)
+
-
Rosendaal, F.R.
(4)
+
-
Toorop, M.M.A.
(4)
+
-
Bos, M.H.A.
(3)
+
-
Buijs, J.T.
(3)
+
-
Cate, H. ten
(3)
+
-
Hulle, T. van der
(3)
+
-
Meijers, J.C.M.
(3)
+
-
Reitsma, P.H.
(3)
+
-
Vermaas, H.W.
(3)
+
-
Versteeg, H.H.
(3)
+
-
Ageno, W.
(2)
+
-
Besselaar, A.M.H.P. van den
(2)
+
-
Boer, A. de
(2)
+
-
Cobbaert, C.M.
(2)
+
-
Coppens, M.
(2)
+
-
Dekkers, O.M.
(2)
+
-
Diener, H.C.
(2)
+
-
Dippel, D.W.J.
(2)
+
-
Dutch COVID Thrombosis Coalition
(2)
+
-
Exter, P.L. den
(2)
+
-
GLORIA-AF Investigators
(2)
+
-
Gardarsdottir, H.
(2)
+
-
Halperin, J.L.
(2)
+
-
Herbel, P.
(2)
+
-
Huisman, M.
(2)
+
-
Kitchen, S.
(2)
+
-
Kooiman, J.
(2)
+
-
Lip, G.Y.H.
(2)
+
-
Stals, M.A.M.
(2)
+
-
Teichert, M.
(2)
+
-
Teutsch, C.
(2)
+
-
Tripodi, A.
(2)
+
-
Zielinski, G.D.
(2)
+
-
Show more
Language
en
(44)
+
-
Search results
(1 - 24 of 44)
Pages
1
2
›
››
show grid
show list
save search
De fining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard
Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation
Early time courses of recurrent venous thromboembolism and bleeding during apixaban or dalteparin therapy for patients with cancer
Clinical controversies in the management of acute pulmonary embolism
Treatment and prevention of cancer-associated thrombosis in the Netherlands
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
Quantitative protein mass-spectrometry requires a standardized pre-analytical phase
Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
Inhaled corticosteroids, vitamin K antagonists and amlodipine were associated with an increased risk of acute periprosthetic joint infection in patients with total hip arthroplasty
The immediate effect of COVID-19 vaccination on anticoagulation control in patients using vitamin K antagonists
Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa
Inter- and intra-individual concentrations of direct oral anticoagulants
Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands
Prophylaxis and treatment of COVID-19 related venous thromboembolism
Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation
Caging the dragon
Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies
High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case-Cohort Study
Anticoagulation practice patterns in COVID-19
Endovascular treatment for acute ischemic stroke in patients on oral anticoagulants results from the MR CLEAN registry
Stroke prevention in atrial fibrillation changes after dabigatran availability in China
Pages
1
2
›
››